Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-08 09:28 am Purchase | 13D | SOL-GEL TECHNOLOGIES LTD SHS SLGL | Arkin Moshe | 18,154,564 60.8% | 4,000,000 (+28.26%) | View |
| 2024-02-22 09:23 am Unchanged | 13D | UROGEN PHARMA LTD URGN | Arkin Moshe | 1,369,315 4.44% | 0 (Unchanged) | View |
| 2023-12-04 06:01 am Sale | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Arkin Moshe | 4,481,126 10.09% | -1,000 (-0.02%) | View |
| 2023-11-24 06:01 am Unchanged | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Arkin Moshe | 4,482,126 10.09% | 0 (Unchanged) | View |
| 2023-04-18 09:59 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Arkin Moshe | 4,482,126 10.15% | 1,769,124 (+65.21%) | View |
| 2023-03-20 4:45 pm Sale | 13D | SOL-GEL TECHNOLOGIES LTD SHS SLGL | Arkin Moshe | 14,154,564 55.08% | -363,702 (-2.51%) | View |
| 2023-02-02 2:25 pm Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Arkin Moshe | 2,713,002 6.16% | 886,776 (+48.56%) | View |
| 2023-02-02 2:23 pm Sale | 13G | KEROS THERAPEUTICS INC KROS | Arkin Moshe | 1,371,074 4.98% | -441,241 (-24.35%) | View |
| 2023-02-02 2:15 pm Purchase | 13G | ONCORUS INC ONCR | Arkin Moshe | 2,508,481 9.66% | 1,041,392 (+70.98%) | View |
| 2022-04-12 06:18 am Unchanged | 13G | KEROS THERAPEUTICS INC KROS | Arkin Moshe | 1,812,315 7.55% | 0 (Unchanged) | View |
| 2022-04-11 4:57 pm Sale | 13G | KEROS THERAPEUTICS INC KROS | Arkin Moshe | 1,812,315 7.55% | -223,825 (-10.99%) | View |
| 2022-03-08 08:58 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Arkin Moshe | 1,826,226 5.38% | 1,826,226 (New Position) | View |
| 2021-12-02 4:15 pm Purchase | 13G | ONCORUS INC ONCR | Arkin Moshe | 1,467,089 5.68% | 1,467,089 (New Position) | View |
| 2021-05-10 11:21 am Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | Arkin Moshe | 2,046,634 7.4% | 2,046,634 (New Position) | View |
| 2020-12-17 06:48 am Unchanged | 13D | KEROS THERAPEUTICS INC KROS | Arkin Moshe | 2,036,140 8.79% | 0 (Unchanged) | View |
| 2020-11-25 06:31 am Unchanged | 13D | KEROS THERAPEUTICS INC KROS | Arkin Moshe | 2,036,140 8.79% | 0 (Unchanged) | View |
| 2020-04-20 1:19 pm Purchase | 13D | SOL-GEL TECHNOLOGIES LTD SHS SLGL | Arkin Moshe | 14,518,266 62.21% | 818,330 (+5.97%) | View |
| 2020-04-20 1:14 pm Purchase | 13D | KEROS THERAPEUTICS INC KROS | Arkin Moshe | 2,036,140 10.6% | 2,036,140 (New Position) | View |
| 2020-02-12 4:16 pm Sale | 13D | UROGEN PHARMA LTD URGN | Arkin Moshe | 1,369,315 6.53% | -8,676 (-0.63%) | View |
| 2020-02-06 1:34 pm Purchase | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | Arkin Moshe | 1,572,394 5.5% | 1,572,394 (New Position) | View |